Predicting relapse after treatment for American cutaneous leishmaniasis [1]

Bulletin of the World Health Organization

Volumn 79, Issue 12, 2001, Pages 1169-

  Romero, Gustavo Adolfo Sierra ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY;

DISEASE CONTROL; LEISHMANIASIS;

DOSE RESPONSE; HUMAN; LEISHMANIA; LETTER; PROGNOSIS; PUBLIC HEALTH; RELAPSE; SKIN LEISHMANIASIS; SKIN TEST; TREATMENT PLANNING;

BRAZIL; COHORT STUDIES; HUMANS; LEISHMANIASIS, CUTANEOUS; PREDICTIVE VALUE OF TESTS; RECURRENCE; SKIN TESTS;

EID: 0035700789     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. American cutaneous leishmaniasis: Use of a skin test as a predictor of relapse after treatment
2. A espécie de Leishmania como principal determinante do prognóstico na leishmaniose tegumentar Americana
3. Leishmania (Viannia) braziliensis is the predominant species infecting patients with American cutaneous leishmaniasis in the State of Minas Gerais, southeast Brazil
4. The use of different concentrations of leishmanial antigen in skin testing to evaluate delayed hypersensitivity in American cutaneous leishmaniasis
5. Cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in Amazonian Brazil, and the significance of a negative Montenegro skin-test in human infections
6. Mucosal Leishmaniasis ("espundia" Escomel 1911)